Delivery Order SPE2DB20D1100-SPE2DB25FE1LW
- Not listed
- The Defense Logistics Agency awarded a $1,131.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of ALBUKED-25 vial 50ML pharmaceutical product. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 1, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,320.60 to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML pharmaceutical products on September 11, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.00 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 Vial 50ML on September 19, 2025, with an ultimate completion date of October 10, 2025. This firm fixed price, non-set-aside delivery order represents a pediatric pharmaceutical product delivery to support federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,368.90 to AmerisourceBergen Drug Corp for ALBUKED-25 VIAL 100ML pharmaceutical product on September 26, 2025, with completion expected by October 20, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $1,140.75 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 VIAL 100ML, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,140.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ALBUKED-25 VIAL 100ML on September 16, 2025, with an ultimate completion date of October 7, 2025. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- The Defense Logistics Agency awarded a $1,320.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of ALBUKED-5 VIAL 250ML pharmaceutical products. The delivery order, which is a child action under a larger contract vehicle, has an ultimate completion date of August 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This non-competitive award reflects the ordering activity under an existing...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,281.50 by the Defense Logistics Agency on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract calls for the delivery of Albuked-25 vial 100ml to support federal medical procurement needs. The delivery order is classified as a child contract under a larger indefinite delivery contract vehicle, reflecting...
- The Defense Logistics Agency awarded a $1,368.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of ALBUKED-25 Vial 100ML pharmaceutical product. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,980.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of ALBUKED-5 VIAL 250ML pharmaceutical product. The contract, which is classified as a child award under a larger indefinite delivery contract vehicle, has an ultimate completion date of October 14, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1LWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,368.90 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 vial 100ML on September 29, 2025, with an ultimate completion date of October 21, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains on a competitively awarded basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/29/25 |